MI4 VM LLC

MI4 advises on the development, utilization, and translation to broader access for cost-effective theranostics programs. Molecular imaging and therapeutics, medical physics, diagnostic radiology, and radiation Oncology have historically been the cornerstones of theranostics. Data science/AI, pathology and equity are now also essential to make theranostics precise. Our goal is to improve on deliverable theranostics by focusing on next-generation molecular imaging and therapeutics. Through Rad Health Equity, a division of MI4, we aim to improve access to radiology through research, advocacy, and practical implementation in underserved communities.